Perhexiline Therapy in Heart Failure With Preserved Ejection Fraction Syndrome
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
Up to half of all patients with clinical features of heart failure are found to have normal
heart pumping function. Recently the investigators have shown that a drug called perhexiline
markedly improved exercise capacity and symptoms in patients with heart failure associated
with impaired cardiac pump function. In this proposal the investigators will assess whether
perhexiline has beneficial effects in patients with heart failure and a normal heart pumping
function.